These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33477971)

  • 1. Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [
    Montes de Jesus F; Vergote V; Noordzij W; Dierickx D; Dierckx RAJO; Diepstra A; Tousseyn T; Gheysens O; Kwee TC; Deroose CM; Glaudemans AWJM
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477971
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of
    Si Z; Lu D; Zhai L; Zheng W; Dong C; Sun C; Wang K; Zhang W; Wei X; Zhang Z; Zhao S; Gao W; Shen Z
    Pediatr Transplant; 2023 Aug; 27(5):e14501. PubMed ID: 36906739
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Montes de Jesus FM; Glaudemans AWJM; Tissing WJ; Dierckx RAJO; Rosati S; Diepstra A; Noordzij W; Kwee TC
    J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and management roles of FDG PET/CT imaging in post-transplant lympho-proliferation in pediatric heart transplantation.
    Brown AK; Carapellucci J; Oshrine B; Gomez A; Meoded A; Asante-Korang A
    Clin Transplant; 2023 Sep; 37(9):e15015. PubMed ID: 37237443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of
    Wang C; Wang G; Wang W; Kan Y; Zhang M; Yang J
    Quant Imaging Med Surg; 2024 Feb; 14(2):1323-1334. PubMed ID: 38415126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
    Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
    Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
    Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
    Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image findings of monomorphic non-hogdkin lymphoproliferative disorder in a post renal transplant patient diagnosed with fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography.
    Kamaleshwaran KK; Rajasekar T; Shibu D; Radhakrishnan EK; Shinto AS
    Indian J Nucl Med; 2014 Jul; 29(3):189-90. PubMed ID: 25210292
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Chen J; Zhang X; Ma L; Gao Y; Fu Z; Liu M
    Front Med (Lausanne); 2023; 10():1258310. PubMed ID: 37663666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.
    Montes de Jesus FM; Kwee TC; Kahle XU; Nijland M; van Meerten T; Huls G; Dierckx RAJO; Rosati S; Diepstra A; van der Bij W; Verschuuren EAM; Glaudemans AWJM; Noordzij W
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):529-536. PubMed ID: 31444510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
    Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
    Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.
    Makis W; Lisbona R; Derbekyan V
    Clin Nucl Med; 2010 Sep; 35(9):704-5. PubMed ID: 20706047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-automated
    Keijzer K; Niezink AGH; de Boer JW; van Doesum JA; Noordzij W; van Meerten T; van Dijk LV
    Comput Struct Biotechnol J; 2023; 21():1102-1114. PubMed ID: 36789266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Tumor Burden Assessed by Dual Time Point [
    Garcia-Vicente AM; Pérez-Beteta J; Pérez-García VM; Molina D; Jiménez-Londoño GA; Soriano-Castrejón A; Martínez-González A
    Mol Imaging Biol; 2017 Aug; 19(4):636-644. PubMed ID: 27981471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic superiority of International Prognostic Index over [
    Montes de Jesus F; Dierickx D; Vergote V; Noordzij W; Dierckx RAJO; Deroose CM; Glaudemans AWJM; Gheysens O; Kwee TC
    EJNMMI Res; 2021 Mar; 11(1):29. PubMed ID: 33738643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.
    Montes de Jesus FM; Kwee TC; Nijland M; Kahle XU; Huls G; Dierckx RAJO; van Meerten T; Gheysens O; Dierickx D; Vergote V; Noordzij W; Glaudemans AWJM
    Crit Rev Oncol Hematol; 2018 Dec; 132():27-38. PubMed ID: 30447925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
    Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
    Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.